Figure 2 Roles of mTOR complexes in the kidney

Slides:



Advertisements
Similar presentations
Human renal primary cells The human kidneys are bean-shaped organs that play several essential regulatory roles. Their main function is to regulate the.
Advertisements

Human renal primary cells The human kidneys are bean-shaped organs that play several essential regulatory roles. Their main function is to regulate the.
Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).
Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Figure 3 LncRNAs in kidney disease
Figure 6 Effects of adiponectin on podocyte function
Figure 4 Expression of coagulation protease receptors in renal cells
Figure 4 Interactions between adipose, the microbiome and kidney
Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 1 Pathological features of lupus nephritis subtypes
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Role of the kidney in glucose homeostasis
Figure 3 The fat–intestine–kidney axis
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Pathogenic mechanisms and pathways in ADPKD
Figure 1 Candidate signalling pathways of irisin in adipocytes
Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.
Figure 7 The efficacy of phosphate-binder therapy
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)
Figure 2 The network of chronic diseases and their mutual influences
Figure 1 The burden of chronic kidney disease (CKD)
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Podocyte dysfunction is a common feature of renal injury
Figure 2 Molecular pathways involved in the regulation of T-cell differentiation and cytokine production Figure 2 | Molecular pathways involved in the.
Figure 1 Acute kidney injury and chronic kidney disease
Figure 4 Altered metabolism in chondrocytes in osteoarthritis
Figure 4 Model of changes in the serum levels
Nat. Rev. Nephrol. doi: /nrneph
Figure 5 Potential roles of phosphate and fibroblast growth factor 23 (FGF-23) in the development of cardiovascular disease in patients with chronic kidney.
Figure 1 The endolysosomal pathway in proximal
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 mTOR complex biology
FGF23–parathyroid interaction: implications in chronic kidney disease
Figure 1 The coagulation system
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Figure 4 The molecular configuration of the CD20 molecule
Figure 3 Loss of the glycocalyx leads to podocyte and kidney injury
Figure 3 Localization of ErbB receptors and ligands within the nephron
Figure 1 The insulin signalling pathway
Nat. Rev. Nephrol. doi: /nrneph
Figure 5 The nephron-centric model of renal transplant fibrosis based on the injury-related molecular events observed in biopsy samples in the first year.
Figure 3 Pathological activation of complement
Figure 3 Biologics that attenuate effector responses in the kidney
Figure 1 Involvement of pVHL in cellular physiology and RCC
Figure 4 Mechanisms of leptin function on kidney injury
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Serum phosphate level is associated with
Figure 3 Regulation of TGF-β1/Smad signalling by microRNAs (miRs) in tissue fibrosis Figure 3 | Regulation of TGF-β1/Smad signalling by microRNAs (miRs)
Figure 4 Senotherapeutic targeting strategies
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanistic classification of lncRNAs
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Main triggers of senescence
Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets
Nat. Rev. Nephrol. doi: /nrneph
Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.
Figure 4 Intracellular distribution and
primary Sjögren syndrome
Nat. Rev. Nephrol. doi: /nrneph
Volume 69, Issue 11, Pages (June 2006)
Molecular origin of the kidney clock
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Nat. Rev. Nephrol. doi: /nrneph
Figure 5 Mechanisms of adiponectin actions in the kidney
Presentation transcript:

Figure 2 Roles of mTOR complexes in the kidney Figure 2 | Roles of mTOR complexes in the kidney. mTOR complexes (mTORCs) are expressed throughout the nephron and regulate homeostasis of all resident parenchymal and non-parenchymal cells. Disruption of mTOR signalling results in various pathologies that are dependent on cellular location and whether mTORC1 or mTORC2 is targeted. In response to mTOR inhibition, proximal tubular epithelial cells downregulate megalin resulting in proteinuria, whereas inhibition of mTOR in distal tubular epithelial cells leads to polyuria, natriuresis and a reduction in inflammatory cell infiltrate and fibroblastic responses following ischaemia–reperfusion injury (IRI). In the glomerulus, mTOR inhibition disrupts podocyte function leading to proteinuria and glomerulosclerosis, whereas endothelial cell proliferation is limited. Ab, antibody; ENaC, epithelial sodium channel; ERK, extracellular signal-regulated kinase; GLUT-12, glucose transporter type 12; NKCC2, Na–K–Cl co-transporter 2; SGK1, serum and glucocorticoid inducible kinase 1; S6RP, S6 ribosomal protein. Fantus, D. et al. (2016) Roles of mTOR complexes in the kidney: implications for renal disease and transplantation Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.108